Benevira is a global, privately owned synthetic biology company focusing on stopping the spread of global viral epidemics and getting ahead of potential outbreaks.
Benevira has recently performed pre-clinical activities with favorable results in both animal and viral studies against both delta and omicron variants of COVID-19.
Benevira continues to develop and manufacture biologics, therapeutics, and consumer health products for patients across the globe.
Benevira has recently performed pre-clinical activities with favorable results in both animal and viral studies against both delta and omicron variants of COVID-19.
Benevira continues to develop and manufacture biologics, therapeutics, and consumer health products for patients across the globe.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2021
Main Therapeutic Focus:
Infectious Diseases
Lead Product in Development:
SARS-CoV-2
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
